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Abstract
Hypoxic ischemic encephalopathy (HIE) is one of the most significant causes of mor-
bidity, mortality, and lifelong disability in newborns. The diagnosis of neonatal HIE is 
based on the dysfunction of neurogenic signs and classification according to the Sarnat 
staging system, which evaluates conscious level, neuromuscular control, complex 
reflexes, autonomic function, seizures, electroencephalogram readings, and duration 
of neurologic sign. There is no standard treatment for neonatal HIE, but it is widely 
accepted that hypothermia therapy is a safe and effective method for treating neonates 
with HIE. Traditional Chinese medicine (TCM) has recently been used to treat cases 
of neonatal HIE, especially herbal medicine prescriptions. Acupuncture is a common 
method used in TCM and is another promising therapy for neonatal HIE due to its dem-
onstrated effective treatment of the disease in animal models. While there is a lack of 
direct evidence in clinical practice, we have observed acupuncture to be useful in adult 
HIE and in animal studies; therefore, we believe a clinical trial designed to evaluate the 
effectiveness of acupuncture in neonatal HIE treatment is worthwhile. Taken together, 
TCM is a promising technique that can be integrated into the conventional therapies for 
neonatal HIE.
Keywords: acupuncture, complementary therapy, herbal medicine, neonatal hypoxic 
ischemic encephalopathy, traditional Chinese medicine
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1. Introduction
1.1. Definition and epidemiology of neonatal hypoxic ischemic encephalopathy
Hypoxic ischemic encephalopathy (HIE) occurs when the cerebral blood flow is disrupted, 
causing a subsequent lack of oxygen to the affected brain area. Neonatal HIE is one of the 
most significant causes of morbidity, mortality and lifelong disability of newborns, which can 
include visual impairment, learning impairment, epilepsy, mental retardation, blindness, and 
cerebral palsy (CP) [1–3]. The incidence of HIE is approximately in 2–9/1000 live births and 
its frequency increases up to 26/1000 newborns in developing countries [1, 3–10]. Nearly 40% 
of HIE newborns cannot survive the neonatal period and another 30% suffer from long-term 
neurological disorders [4, 11, 12].
1.2. Cause of neonatal HIE
HIE is caused by a number of reasons, including severe hypoxia, hypotension, or infection 
during prenatal development; uterine rupture, cord occlusion or prolapse, abruption or pla-
cental insufficiency during perinatal development; shock; and respiratory or cardiac arrest 
during postnatal periods [3, 13].
1.3. Pathophysiology of neonatal HIE
The pathogenesis of HIE can be divided into the following steps after injury (Figure 1) [1, 3, 
4, 9, 10]:
i. First 60 min: Due to lack of glucose and oxygen delivery to the brain, anaerobic res-
piration cannot produce sufficient adenosine triphosphate (ATP) and causes failure of 
ATP-dependent Na+/K+-pumps [1, 3, 4, 9, 10]. This phenomenon results in Ca2+ and Na+ 
influx and cell membrane depolarization [1, 3, 4, 9, 10]. When the membrane depolar-
izes, the cells release excitatory glutamate [1, 3, 4, 9, 10]. Glutamate can activate N-me-
thyl-D-aspartate (NMDA) and a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA) receptors, which increases Ca2+ influx into cells and causes cell apoptosis [1, 
3, 4, 9, 10]. Furthermore, hypoxia inducible factor-1α (HIF-1α) is also upregulated in 
these conditions, which will then bind to HIF-1β to form HIF-1α/β complex and traf-
fic to nucleus, where it activates downstream genes, such as erythropoietin (EPO) and 
vascular endothelial growth factor (VEGF), to rescue this situation after brain injury 
[9]. Hydrogen sulfide (H2S) is a novel neuromodulator that is produced by cystathio-nine β-synthase (CBS) in brain tissue, especially the hippocampus, and can modulate 
NMDA receptor activity [14]. H2S plays an important role in ischemic brain damage 
and the inhibition of H2S levels could serve as a therapeutic strategy to protect neuron damage in HIE [15].
ii. Between 1 and 48 h: Acute inflammation, oxidative metabolism, and continuation of acti-
vated apoptotic cascades take place in this stage of HIE [1, 3, 4, 9, 10]. Because of the Ca2+ 
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accumulation in cells, production of nitric oxide (NO) by neuronal nitric oxide synthase 
(nNOS) is elevated and generates reactive oxygen species (ROS) caused by mitochondria 
(mt) injury [1, 3, 4, 9, 10]. Furthermore, lipid peroxidation is induced by intracellular ROS 
level elevation [1, 3, 4, 9, 10], and Bcl-2 expression levels are reduced, while Bax expres-
sion is increased, leading cells to undergo apoptosis [9]. Carbon monoxide (CO) is an en-
dogenous molecule that is generated from the degradation of heme by heme-oxygenase 
(HO) might serve as an neuroprotective reagent because it can reduce inflammation, anti-
apoptosis, and induce vasodilation in HIE rats [16].
iii. Days to months: At this point, chronic inflammation, late cell death, remodeling and re-
pair of the injured brain tissue, and astrogliosis (abnormal increase of astrocytes due to 
brain damage) occur [1, 3, 4, 9, 10]. Brain-derived neurotrophic factor (BDNF) and glial 
cell line-derived neurotrophic factor (GDNF) are two important factors that have benefi-
cial effects on brain repair and remodeling in HIE [17–20].
Figure 1. Pathophysiology of neonatal hypoxic ischemic encephalopathy. Generally speaking, the pathophysiology 
of neonatal HIE can be divided into three major steps. (1) In the first 60 min: HIE is caused by reduced glucose and 
oxygen delivery to the brain, which causes anaerobic respiration. This phenomenon will reduce ATP production from 
one molecule of glucose (38 ATP → 2 ATP). The reduction of ATP will initially influence the ion content in cells, and then 
glutamate will accumulate outside the cells and induce cell apoptosis by activating the NMDA and AMPA receptors to 
transport more Ca2+ into cells. However, HIF-1α will be upregulated to modulate downstream genes involved in cell 
rescue. (2) In the next 1–48 h: due to Ca2+ accumulation in cells, nNOS and ROS increase, which causes lipid peroxidation 
and induce cell apoptosis. Furthermore, excess Ca2+ will reduce Bcl-2 expression and increase Bax expression, also leading 
cells to undergo apoptosis. In addition, CO might play an important role in preventing immune cell recruitment, decrease 
the inflammatory response, inhibit cell apoptosis, and promote vasodilation. (3) In the days to months following the 
initial HIE onset: BDNF and GDNF might be involved in many signaling cascades responsible for brain tissue repair and 
remodeling. * Partial figure design was provided by Hsiao-Han Hsu.
Complementary Therapy with Traditional Chinese Medicine for Neonatal Hypoxic Ischemic…
http://dx.doi.org/10.5772/intechopen.76373
91
1.4. Diagnosis and classification of neonatal HIE
Any abnormal heart rate or other signs of neonate distress during delivery and respiratory 
problems, improper Apgar scores, seizures, unconsciousness and so on after birth are warning 
sings to suspect neonatal HIE. There is no currently available bedside test for accurate diagno-
sis of neonatal HIE [1]. The diagnosis of HIE is based on the signs of neurogenic dysfunction 
such as abnormality of muscle power and tone, reduced consciousness and respiration, func-
tional disruption of the cranial nerve, and seizures [1, 21]. Metabolic acidosis and low Apgar 
scores are associated with neuronal dysfunction; moreover, metabolic acidosis is significantly 
related to HI injury [1, 21]. Furthermore, the image pattern of magnetic resonance imaging 
(MRI) may provide further evidence for HIE diagnosis [1]. Classification of neonatal HIE fol-
lows the Sarnat staging system, which is divided into three categories—stage I (mild), stage II 
(moderate), and stage III (severe)—that are used to evaluate the following parameters: level of 
consciousness, neuromuscular control, complex reflexes, autonomic function, seizures, elec-
troencephalogram readings, and duration [1, 22].
1.5. Treatment of neonatal HIE
1.5.1. Systemic support
The basic care of neonatal HIE is systemic support, which is very important to maintain 
the cerebral blood flow that ensures glucose and oxygen supply to the brain to prevent 
further injury [1]. Neonates with HIE produce less carbon dioxide (CO2) due to changes in energy metabolism and need less ventilator support to maintain suitable levels of CO2 [1, 23]. Insufficient CO2 (hypocapnia) is related to high mortality and poor development of neu-ron function [1, 23, 24]. In addition, too much oxygen (hyperoxia) is also hazardous in neo-
nates with HIE because it can enhance oxidative stress and free radical formation that might 
increase mortality and poor outcome [1, 24]. Therefore, maintaining suitable CO2 and O2 lev-els at PaCO2 40–55 mmHg and PaO2, 50–100 mmHg, respectively, may prevent further brain injury in neonates with HIE [1]. Blood pressure must also be maintained to avoid hypotension 
in newborn HIE because it could prevent further ischemic brain injury [1]. Unfortunately, 
there is no evidence of what the ideal mean arterial blood pressure (MAP) is in cases of neo-
natal HIE [1].
1.5.2. Fluids and nutrition
For the best long-term outcomes, the initial optimal rate of fluid therapy is not established 
but the most common practice is to start intravenous 10% dextrose solution combined with 
sodium and add proper electrolytes based on the results of serum electrolytes [1]. It is sug-
gested that carefully managing fluid therapy in neonates with HIE is helpful in preventing 
brain edema [1, 25]. Research has shown that hypoglycemia is associated with a high Sarnat 
stage grade and is an important factor for severe brain injury [1, 26, 27]. Under normal physi-
ological conditions, the adult brain uses nearly 100% glucose as an energy source, but in 
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neonate brains, glucose may account for only 70% [1, 28]. Despite neonate brains being able 
to use other substrates as energy such as lactate or ketones, these alternative substrates may 
not compensate for the lack of glucose [1, 28]. In other words, monitoring fluid and glucose 
strictly is very important in preventing brain edema and hypoglycemia in newborns with HIE 
and might be helpful in reducing further brain damage [1].
1.5.3. Hypothermia
It is widely accepted that hypothermia therapy is a safe and effective way to treat neonatal 
HIE and could reduce morbidity and mortality [1, 3, 29–31]. Many studies have shown that 
keeping neonatal HIE subjects 2–3° below the normal brain temperature can prevent fur-
ther neurological damage; one of the possible mechanisms for this might be associated with 
reduce carbon biomass related to acetyl moieties such as pyruvate and acetyl-CoA [3, 32–34]. 
Other possible mechanisms of neuroprotection from HIE symptoms like inactive microglia 
cells could be the reduction of apoptosis pathways by decreased caspase-3 activity, decreased 
NMDA receptor activity, preservation of lipoprotein membrane integrity, and decreased 
inflammatory responses [35–40]. Therapeutic hypothermia is a part of current standard treat-
ments of neonates with moderate to severe HIE [41].
1.5.4. Medication for seizure control
The best medication for seizure control in neonates with HIE is not well standardized [1]. 
Phenobarbital, a frequently prescribed drug by physicians, can only control seizure attacks 
in 27% of patients [1]. Two promising anti-seizure drugs, topiramate and levetiracetam, need 
more clinical trials to prove their efficacy in neonates with HIE [1]. In one animal study and 
one human pilot clinical trial, topiramate was shown to work synergistically with hypother-
mia therapy [1, 42]. Levetiracetam is reported to reduce neuron cell apoptosis and decrease 
excitotoxicity in general, and one animal study showed these effects are also appearing in 
neonatal HIE rats [1, 43].
2. Traditional Chinese medicine in the treatment of neonatal HIE
2.1. TCM perspective of neonatal HIE
Neonatal HIE can be classified into “tai jing, 胎驚”, “tai shian, 胎癇”, “jing feng, 驚風”, and 
“huan mi, 昏迷” in TCM. In mild and moderate grades of neonatal HIE, the common TCM 
diagnostic pattern are “deficiency of qi and blood, 氣血不足” and “qi obstruction and blood 
stasis, 氣滯血瘀”. The best therapeutic principles are “supplementing qi and nourishing 
blood, 益氣養血” and “promoting qi circulation to remove blood stasis, 行氣化瘀”. In severe 
grade one, the most common diagnostic pattern is “phlegm stasis causing wind, 痰瘀生風” 
and the therapeutic principle is “tranquilize mind and arresting convulsion, 化痰定驚”. To 
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reach this goal, TCM physicians can use herbal medicine or acupuncture in the treatment of 
neonatal HIE, which we will discuss in the following section.
2.2. Acupuncture therapy for neonatal HIE
2.2.1. Clinical trial
Currently, there are no suitable clinical trials that have demonstrated that acupuncture can 
improve the prognosis of neonatal HIE, as acupuncture has only been evaluated in older 
infants who survived HIE [44]. CP is one of the consequences of HIE that acupuncture might 
have some beneficial effects in children [45–49]. Clinical evidence showed that acupuncture 
therapy intervention could improve the quality of life and promote improvements in speech 
and language impairment, neural function, motor disability, and cognition [45, 46, 50–53]. 
Although there is no current clinical trial evidence that acupuncture therapy could be used 
in neonates with HIE, there are many basic research studies have already demonstrated that 
acupuncture has the potential to be an intervention option for neonatal HIE.
2.2.2. The possible mechanism of acupuncture therapy for neonatal HIE
Because it is widely accepted by patients, physicians and scientists that acupuncture therapy 
can be used to improve many brain-related diseases such as stroke and Alzheimer disease [54, 
55], many researchers are devoted to investigating the possibility of treating neonates with 
HIE with acupuncture therapy (Table 1).
In 2010, Liu et al. [56] showed that electro-acupuncture (EA) could protect against brain dam-
age caused by HIE by reducing hydrogen sulfide (H2S) generation in neonatal rats. In this study, they treated acupoints Dazhui (DV14, 大椎) and Baihui (DV20, 百會) using needles 
0.25 mm in diameter and 10 mm long and an electrical wave frequency 2/100 Hz at an inten-
sity of 3 mA for 30 min/day with 14 continuous days starting the second day after the neonatal 
HIE rat model was established [56]. The results showed that EA could increase cerebral blood 
flow and motor function when compared to the no treatment group [56]. They also measured 
the expression of CBS, an enzyme that can produce H2S in brain tissue and is elevated in HIE, in the EA-treated group and found reduced expression compared to the untreated control 
[56]. In 2011, the same therapeutic protocol was also associated with the NO/nNOS system; 
EA could reduce NO levels and nNOS expression of the cortex compared with the no treat-
ment group [57]. In addition, the expression of nNOS might be related to the nuclear factor-κB 
(NF-κB) pathway that EA could reduce the nNOS expression level via reducing the NF-κB 
generation [58]. In 2014, DV14 and DV20 stimulated by EA elevated CO levels and HO-1 in 
HIE neonatal rats, which might protect against neuron damage [59]. Chao et al. [60] showed 
that applying manual acupuncture (MA) using needles 0.18 mm in diameter and 13 mm long 
at Baihui (DV20, 百會) and Shuaigu (GB8, 率谷) for 30 min/day with 30 s twirling and rotation 
every 5 min during each MA treatment, 2 days before HIE established and 7 days after HIE 
was induced, could reduce neonatal rat brain injury. They found that this treatment protocol 
could balance K+ after HIE, probably through activation of the δ-opioid receptor (DOR) in the 
brain [60].
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An article published by Xu et al. [61] showed that EA could protect against neuron dam-
age after HIE and might be associated with the GDNF/rearranged during transfection (RET) 
receptor pathway. This study choose Baihui (GV 20, 百會), Dazhui (GV 14, 大椎), Quchi (LI 
11, 曲池), and Yongquan (KI 1, 湧泉) for acupuncture therapy using needles 13 mm long, and 
EA with asymmetric bidirectional continuous pulse waves with a frequency of 5–10 Hz and 
an intensity 3–5 V, which was performed at GV20 and LI11 for 10 min/day for continuous 
21 days [61]. These results showed that after treatment, the RET receptor and its key down-
stream phosphatidylinositol 3 kinase (PI-3 K)/protein kinase B (Akt), increased in expression 
in a dose dependent manner (sham EA compared with EA treated for 1, 3, 7, and 21 days) [61]. 
Acupoints Treatment protocol Possible mechanism Reference
Dazhui (DV14, 大椎), 
Baihui (DV21, 百會)
Needles: 0.25 mm in diameter and 
10 mm long
Method: EA with electrical wave 
frequency 2/100 Hz and intense 3 mA
Treatment time: 30 min/day with 
14 days
1. Reduce H2S level by decreasing the expression level of CBS
2. Reduce NO level by decreasing the 
expression of nNOS through the NF-
κB pathway
3. Increase CO level in cortex by en-
hancing HO-1 expression
[56–59]
Baihui (DV20, 百會), 
Shuaigu (GB8, 率谷)
Needles: 0.18 mm in diameter and 
13 mm long
Method: MA with twirling and 
rotating for 30 s every 5 min during 
each MA treatment
Treatment time: 30 min/day, 2 days 
before established HIE and 7 days 
after established HIE
Attenuating ischemic disruption of K+ 
homeostasis via activated DOR
[60]
Baihui (GV 20, 百會), 
Dazhui
(GV 14, 大椎), 
Quchi (LI 11, 曲池), 
Yongquan (KI 1, 湧
泉)
Needles: 13 mm long, diameter not 
available in Ref.
Method: EA with asymmetric 
bidirectional continuous pulse wave 
frequency 5–10 Hz and intensity 
3–5 V at GV20 and LI11
Treatment time: 10 min/day with 
21 days
GDNF, RET receptor and Akt were 
increased expression
[61]
Baihui (GV 20, 百會), 
Si shencong (Ex-HN 
1, 四神聰)
Needles: 0.3 mm in diameter and 
25 mm long
Method: MA with twirling at a rate 
of 2 spins/s for 15 s when needles 
insertion in each acupoint and the 
needles were twirled for 3 min every 
10 min
Treatment time: 30 min/day with 
28 days (MA performed for 5 days 
and 2 days of rest)
1. Attenuated brain cell apoptosis
2. Up-regulated BDNF and GDNF ex-
pression level
[62]
Table 1. The commonly used acupoints and possible mechanisms of neonatal hypoxic ischemic encephalopathy 
acupuncture.
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Based on these data, the authors suggested that the longer duration acupuncture treatment 
had better therapeutic effects on reducing neuron damage after HIE [61].
Zhang et al. [62] found that acupuncture at Baihui (GV 20, 百會) and Si shencong (Ex-HN 1, 
四神聰) could reduce neuron damage after HIE. One day after neonatal HIE rat model was 
established, therapy included 0.3 × 25 mm needles that were twirled at a rate of two spins per 
second for 15 s, and then retained for 30 min at GV20 and Ex-HN1 [62]. At the needle reten-
tion interval, the needles were twirled three times for 3 min [62]. The acupuncture therapy 
was performed for five consecutive days followed by 2 days of rest and was performed over 
a total of 28 days [62]. The results showed that neurobehavioral function, and learning and 
memory abilities were improved after 20 days of treatment [62]. In addition, this study sug-
gested that the possible mechanism of the acupuncture treatment might be associated with 
anti-apoptosis and upregulated GDNF and BDNF expression levels in the brain [62].
2.3. Herbal medicines for neonatal HIE
2.3.1. Clinical trial
Herbal medicines, including single herb and formulas (combination with different ingre-
dient herb), have beneficial effects on brain HI injury. For example, treating neonates 
with HIE with a combination of Panax notoginseng saponins and conventional therapy 
can significantly reduce central respiratory failure, circulation dysfunction and gastroin-
testinal symptoms when compared to neonates treated only with conventional therapy 
[63]. Furthermore, the level of Ca2+ in red blood cells decreased significantly in the Panax 
notoginseng saponins treated group [63]. Research has also shown that conventional ther-
apy combined with Salvia miltiorrhiza, Ligusticum chuanxiong, Ginkgo biloba, and Astragalus 
propinquus can improve the clinical outcome of HIE [64]. Some formulas such as Xuefu 
Zhuyu Decoction (血府逐瘀湯), Sheng Mai Yin (生脈飲), and An Gong Niu Huang Wan (安
宮牛黃丸) are also known to improve the prognosis of neonates with HIE when combined 
with conventional therapy [64]. Considerable research has provided us a possible mecha-
nism for how these herbal medicines and formulas work in HIE treatment, and we discuss 
this in the following sections.
2.3.2. Possible mechanisms of different single herbs for neonatal HIE remedies
In this section, we briefly discuss and summarize some single herbs and their possible phar-
macological mechanism on neonatal HIE (Table 2).
i. Panax ginseng (人參)
Ginseng, the root and rhizome of Panax ginseng C A Meyer, has been used as a tonic herb for 
over 2000 years [65]. Ginsenoside Rg1 is one of the ingredients that is extracted from Ginseng 
and might improve brain repair after HIE [65]. Rg1 could increase neural viability, promote 
angiogenesis, and induce neurogenesis by increasing HIF-1α expression [65]. In addition, the 
expression of HIF-1α expression by Rg1 via cellular signaling pathway such as PI-3 K/Akt and 
extracellular signal-regulated kinase (ERK) was demonstrated [65].
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ii. Salvia miltiorrhiza (丹參)
Salvia miltiorrhiza is a common drug used for promoting blood circulation and removing 
blood stasis “活血化瘀” [66, 67]. Research has shown that tanshinone IIA, an important com-
ponent of Salvia miltiorrhiza, might have neuronal protective, anti-apoptosis effects by inhibit-
ing caspase-3 activity after HIE [66]. In addition, tanshinone IIA can reduce inflammation by 
decreasing the expression level of TNF-α and IL-1β in HIE brain tissue [67].
iii. Ligusticum chuanxiong (川芎)
Ligustrazine, a component extracted from Ligusticum chuanxiong, has known to have effect 
of neuron protection [68, 69]. Ligusticum chuanxiong is a herb which is widely used to active 
blood and promote qi circulation “活血行氣” [68, 69]. In modern research, ligustrazine can 
increase the expression level of HIF-1α, which can activate many downstream pathways that 
protect neuron damage in HI conditions [68]. Furthermore, ligustrazine can reduce neuron 
cell apoptosis through increasing the Bcl-2 gene expression and decreasing the Bax gene 
expression [69].
iv. Astragalus propinquus (黃耆)
Astragalus propinquus is a tonic herb that is used to invigorate qi for ascending “補氣升陽”, 
and nourish blood and promote granulation “養血生肌” [70]. In a recent study, it was demon-
strated that Astragalus propinquus can improve neural behavior by increasing the expression 
level of VEGF and VEGF receptor-2 (VEGFR-2) [70], which play important roles in ameliorat-
ing cognitive impairment in ischemic brain tissue in vitro and in vivo by improving neuronal 
cell viability and function [71].
v. Radix Puerariae (葛根)
Puerarin is extracted from Radix Puerariae, which has been demonstrated to reduce neuronal 
apoptosis after HI injury [72, 73]. The possible mechanism of puerarin is the downregulation 
of Bax and Caspase-3 levels by increasing the expression of BDNF [72]. In addition, puerarin 
can reduce ROS, prevent excess Ca2+ reflux into cells, and decrease inflammatory responses 
caused during HI injury [72]. Furthermore, the Bim protein can promote cell apoptosis and 
can also be downregulated by puerarin [73].
vi. Gastrodia elata (天麻)
Gastrodia elata belongs to Orchidaceae family and is used as a herbal medicine for its pharma-
cologic function of relieving convulsion and spasm “息風止痙”, suppressing liver yang “平抑
肝陽”, and expelling wind evil and channel “袪風通絡” [74]. It is a promising neuroprotective 
herb that might have been used in many incurable neural diseases such as Alzheimer’s dis-
ease (AD), Parkinson’s disease (PD), stroke, and seizure because this herb was demonstrated 
that could reduce neuron cell apoptosis via reducing neuron cell damage by free radical, 
inhibiting Ca2+ influx into cells and decreasing the neuron toxicity by counteracting glutamate 
effect [75]. The expression of doublecortin in brain tissue can be upregulated by Gastrodia 
elata, and this phenomenon is beneficial for brain injury because it can increase neuron cell 
migration and differentiation [74].
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vii. Ginkgo biloba (銀杏)
The extractions from the Ginkgo biloba leaf are widely used in the treatment of aging-related 
diseases such as AD, cerebrovascular disease, and macroangiopathy [76]. The possible mecha-
nism of Ginkgo biloba leaf extraction might be associated with its anti-oxidative properties 
such as scavenging free radicals, regulation of oxidative stress, and anti-lipid peroxidation; 
Herbal medicine Possible mechanism Reference
Panax ginseng (人參) 1. Increases neural viability, promotes angiogenesis, and 
induces neurogenesis by targeting hypoxia HIF-1α.
2. Involves the cellular signaling pathway PI-3 K/Akt 
and ERK upstream of HIF-1α.
[65]
Salvia miltiorrhiza (丹參) 1. Neuronal protective effect by inhibiting caspase-3  
activity after HIE, which inhibits apoptosis.
2. Reduces inflammation by decreasing the expression 
level of TNF-α and IL-1β in HIE brain tissue.
[66, 67]
Ligusticum chuanxiong (川芎) 1. Increases the expression of HIF-1α, which can acti-
vate many downstream pathways that can protect 
neuronal damage in HI conditions.
2. Reduces neuron cell apoptosis by increasing Bcl-2 gene 
expression and decreasing the Bax gene expression.
[68, 69]
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Herbal medicine Possible mechanism Reference
Astragalus propinquus (黃耆) Improves neural behavior by increasing the expression 
level of VEGF and VEGFR-2, which might be associated 
with ameliorating cognitive impairment in ischemia 
brain tissue in vitro and in vivo through improvement of 
neuron cell viability and function.
[70, 71]
Radix Puerariae (葛根) 1. Decreases apoptosis by down-regulating the level of 
Bax and Caspase-3, which increases the expression of 
BDNF.
2. Reduces ROS, prevents excess Ca2+ influx into cells, 
and decreases the inflammatory response to HI injury.
3. Prevents apoptosis by down-regulating the Bim 
protein.
[72, 73]
Gastrodia elata (天麻) Increases neuron cell migration and differentiation by 
elevating the expression of doublecortin.
[74]
Ginkgo biloba (銀杏) 1. Associated with anti-oxidative properties, protection 
against oxidative DNA damage, and regulation of mt 
damage.
2. Promotes brain tissue repair by increasing nestin 
protein expression and inducing neural stem cell 
proliferation.
[76, 77]
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protecting DNA damage from oxidative damage; regulating mt damage such as inhibiting 
mt-induced ROS, and decreasing mt-related apoptosis [76]. In addition, the extract of Ginkgo 
biloba leaves can increase nestin protein expression, which can promote brain tissue repair by 
inducing neural stem cells proliferation [77].
viii. Rhodiola rosea (紅景天)
Rhodiola rosea is a widely used herbal medicine in Asia and Eastern Europe for enhancing 
physical and mental performance [78]. More recently, this plant has been used as an additive 
in food, beverages, and dietary supplements [78, 79]. Rhodiola rosea extract might function 
as an HIE treatment by increasing the expression level of HIF-1α in the endothelium cells of 
brain vessels, cerebral cortex, and hippocampus [80].
ix. Panax notoginseng (川七)
Panax notoginseng saponins are important components in Panax notoginseng that are a prom-
ising reagent for HIE therapy because they have a protective effect that is associated with the 
Herbal medicine Possible mechanism Reference
Rhodiola rosea (紅景天) Increases the expression level of HIF-1α in endothelium 
cells of brain vessels, cerebral cortex, and hippocampus.
[80]
Panax notoginseng (川七) 1. Reduces the damage caused by free radicals and  
decreases Ca2+ influx into neuron cells.
2. Promotes blood circulation in the brain by a vessel 
dilating effect.
[81]
*All herbal medicine samples were kindly provided by Long Zhi De Chinese Medicine and Biotechnology Co., Ltd.
Table 2. Possible mechanisms of herbs used for neonatal HIE treatment.
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reduction of free radicals and Ca2+ influx into neuron cells, which can limit cellular damage 
after HIE onset [81]. Furthermore, it can also serve as a vasodilator and increase the circula-
tion in the brains of HIE patients [81].
2.3.3. Possible mechanism of different herbal formulas for neonatal HIE
Formula is a combination of different single herbs used to treat many kinds of diseases. The 
beneficial of formula is that after combing different herbs together which could reduce tox-
icity and side effect if we only used too many same single herbs. Here we briefly introduce 
some herbal formulas that are beneficial in neonatal HIE therapies (Table 3).
i. Xuefu Zhuyu Decoction (血府逐瘀湯)
Xuefu Zhuyu Decoction is from “Correction on Errors in Medical Classics (醫林改錯)” written 
by Qing-Ren Wang (王清任) [64]. Because this formula is widely used to promote blood circu-
lation and remove blood stasis “活血化瘀”, this formula could reduce the viscosity of blood 
and lead to an increase the blood circulation [64]. Studies have shown that this formula could 
improve neural behavior in neonatal rats with HIE on day 6 after neonatal HIE rat model 
was established, compared to the saline treated control group [82]. In addition, Xuefu Zhuyu 
Decoction could maintain or slightly increase nerve growth factor (NGF) expression on day 6, 
while NGF expression levels decreased in the saline-treated control group [82]. These results 
suggest that Xuefu Zhuyu Decoction might protect neuron cells after HI injury by up-regu-
lating NGF expression [82]. NGF is a neurotrophy, which can support the differentiation and 
survival of neuron cells and have anti-apoptotic and anti-oxidative effect which is showed to 
have beneficial effects on neonatal HIE rat [83].
ii. Sheng Mai Yin (生脈飲)
This formula consists of Panax ginseng (人參), Liriope spicata (麥門冬), and Schisandra chi-
nensis (五味子) and is widely used to supplement qi and nourish yin “益氣養陰”, reduce 
resuscitation and recuperate depleted yang “回陽固脫”, and promote blood circulation and 
remove blood stasis “活血化瘀” [64]. A pharmacologic study showed that this formula can 
eradicate free radicals, inhibit lipid peroxidation, improve microcirculation, and increase 
Formulas Possible mechanism Reference
Xuefu Zhuyu 
Decoction
(血府逐瘀湯)
1. Increases blood circulation by decreasing blood viscosity.
2. Improves neural behavior by up-regulating NGF expression.
[64, 82]
Sheng Mai Yin
(生脈飲)
1. Eradicates free radicals, inhibits lipid peroxidation, improves microcirculation, 
and increases cell resistance to hypoxia.
2. Rescues brain hypoxia and ischemic injury by improving the metabolism of the 
heart, increasing myocardial cells contraction, and cardiac output.
[64]
An Gong Niu 
Huang Wan
(安宮牛黃丸)
Eradicates free radicals and reduces edema in the brain by decreasing vascular 
permeability and increasing hypoxia resistance.
[64, 84]
Table 3. Possible mechanisms of herbal formulas for neonatal HIE treatment.
Complementary Therapy with Traditional Chinese Medicine for Neonatal Hypoxic Ischemic…
http://dx.doi.org/10.5772/intechopen.76373
101
neuron cell resistance to hypoxia and other cellular stress [64]. In addition, Sheng Mai Yin 
can also improve the metabolism of heart and increase myocardial cells contraction and 
cardiac output to rescue hypoxia and ischemic injury of the brain [64]. Taken together, 
Sheng Mai Yin can prevent nerve cells damage after HIE via reducing neuron cell apopto-
sis, increasing neuron cell resistance to hypoxia and stress, increasing brain circulation [64].
iii. An Gong Niu Huang Wan (安宮牛黃丸)
An Gong Niu Huang Wan is a formula that can remove qi and blood obstruction, smooth 
circulation, and stop pains with aromatics “芳香開竅”, awaking brain and reliving spasm 
“醒腦止痙”, clear away heat and toxic materials “清熱解毒” and cool blood and promoting 
qi circulation “涼血行氣” [64]. A biomedical study showed that An Gong Niu Huang Wan 
could eradicate free radicals in brain tissue and reduce brain edema by decreasing vascular 
permeability and increasing neuron cell resistance to hypoxia [64, 84].
3. Discussion and conclusion
Current advances in medical technology have increased, but there is still no standard and 
effective treatment for neonatal HIE. The widely accepted treatment for neonatal HIE is hypo-
thermia therapy that has been demonstrated to reduce morbidity and mortality in newborns 
[1, 3, 29–31]. Many researchers and physicians hope to find the best way to treat this dis-
ease and devote themselves to the investigation and development of new therapeutic agents 
and stem cells transplantation therapy [1]. Recently, many basic researches showed that TCM 
(including herbal medicine and acupuncture) treatment was involved in many molecular 
pathways which might be beneficial to neonatal HIE for example, reducing H2S and NO level, increasing CO level, keeping ion homeostasis, up-regulating BDNF, GDNF and NGF, scaveng-
ing free radicals and so on in neural cells to prevent cells apoptosis and further damage. Due to 
abovementioned reasons, integrating Chinese Medicine to treat neonatal HIE is one promising 
method toward a better prognosis. Here we review many kinds of herbal medicines and for-
mulas used in clinical practice in China and show that in with standard treatment, these herbs 
and formulas can improve the prognosis of neonatal HIE. In addition, acupuncture therapy 
is also a promising method to treat neonates with HIE, but unfortunately there are no suit-
able clinical trials that report the effect of acupuncture on neonatal HIE. However, it is worth 
mentioning that acupuncture therapy of adults with HIE is very useful [85]. In our experience, 
the Acupoints of Regain Consciousness (ARC) “醒腦開竅方” and Acupoints of Recover from 
Paralysis (ARP) “疏經活絡方” established by Dr. Wen-Long Hu are very useful in cases of 
adult HIE, and these acupoints are listed as the following: ARCs including 12 Jing-Well points 
(十二井穴), Frontal-top belt (額頂帶), Top-temporal belt (頂顳帶) and Renzhong (DU 26, 人中); 
and ARPs including Quchi (LI 11, 曲池), Hegu (LI 4, 合谷), Zusanli (ST36, 足三里), Sanyinjiao 
(Sp 6, 三陰交), Yanglingquan (GB 34, 陽陵泉) and three brain needle (腦三針) [85].
To conclude, although there is still a lack of clinical studies for demonstrating that acupunc-
ture is suitable and beneficial for the treatment of neonates with HIE, many animal studies 
have demonstrated that acupuncture has potential as a treatment for neonatal HIE in clinical 
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practice, and its effectiveness for treating the symptoms of neonatal HIE should be evaluated. 
Based on current research and our clinical practice, we believe integrating conventional ther-
apy with TCM is a promising therapeutic method for neonatal HIE.
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